These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 32528976)

  • 1. LDL Receptor Pathway Regulation by miR-224 and miR-520d.
    Salerno AG; van Solingen C; Scotti E; Wanschel ACBA; Afonso MS; Oldebeken SR; Spiro W; Tontonoz P; Rayner KJ; Moore KJ
    Front Cardiovasc Med; 2020; 7():81. PubMed ID: 32528976
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hepatic overexpression of idol increases circulating protein convertase subtilisin/kexin type 9 in mice and hamsters via dual mechanisms: sterol regulatory element-binding protein 2 and low-density lipoprotein receptor-dependent pathways.
    Sasaki M; Terao Y; Ayaori M; Uto-Kondo H; Iizuka M; Yogo M; Hagisawa K; Takiguchi S; Yakushiji E; Nakaya K; Ogura M; Komatsu T; Ikewaki K
    Arterioscler Thromb Vasc Biol; 2014 Jun; 34(6):1171-8. PubMed ID: 24675665
    [TBL] [Abstract][Full Text] [Related]  

  • 3. High-Throughput Screening Identifies MicroRNAs Regulating Human PCSK9 and Hepatic Low-Density Lipoprotein Receptor Expression.
    van Solingen C; Oldebeken SR; Salerno AG; Wanschel ACBA; Moore KJ
    Front Cardiovasc Med; 2021; 8():667298. PubMed ID: 34322524
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Suppression of Idol expression is an additional mechanism underlying statin-induced up-regulation of hepatic LDL receptor expression.
    Dong B; Wu M; Cao A; Li H; Liu J
    Int J Mol Med; 2011 Jan; 27(1):103-10. PubMed ID: 21069265
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Role of PCSK9 and IDOL in the pathogenesis of acquired LDL receptor deficiency and hypercholesterolemia in nephrotic syndrome.
    Liu S; Vaziri ND
    Nephrol Dial Transplant; 2014 Mar; 29(3):538-43. PubMed ID: 24166456
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Targeted disruption of the idol gene alters cellular regulation of the low-density lipoprotein receptor by sterols and liver x receptor agonists.
    Scotti E; Hong C; Yoshinaga Y; Tu Y; Hu Y; Zelcer N; Boyadjian R; de Jong PJ; Young SG; Fong LG; Tontonoz P
    Mol Cell Biol; 2011 May; 31(9):1885-93. PubMed ID: 21343340
    [TBL] [Abstract][Full Text] [Related]  

  • 7. microRNA-185 modulates low density lipoprotein receptor expression as a key posttranscriptional regulator.
    Jiang H; Zhang J; Du Y; Jia X; Yang F; Si S; Wang L; Hong B
    Atherosclerosis; 2015 Dec; 243(2):523-32. PubMed ID: 26523989
    [TBL] [Abstract][Full Text] [Related]  

  • 8. IDOL, inducible degrader of low-density lipoprotein receptor, serves as a potential therapeutic target for dyslipidemia.
    Zhang CP; Tian Y; Zhang M; Tuo QH; Chen JX; Liao DF
    Med Hypotheses; 2016 Jan; 86():138-42. PubMed ID: 26601593
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of statins on the inducible degrader of low-density lipoprotein receptor in familial hypercholesterolemia.
    Chan ML; Shiu SW; Cheung CL; Yu-Hung Leung A; Tan KC
    Endocr Connect; 2022 Jun; 11(6):. PubMed ID: 35560019
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Plasma inducible degrader of the LDLR, soluble low-density lipoprotein receptor, and proprotein convertase subtilisin/kexin type 9 levels as potential biomarkers of familial hypercholesterolemia in children.
    Girona J; Rodríguez-Borjabad C; Ibarretxe D; Heras M; Amigo N; Feliu A; Masana L; Plana N;
    J Clin Lipidol; 2018; 12(1):211-218. PubMed ID: 29102496
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Post-transcriptional regulation of lipoprotein receptors by the E3-ubiquitin ligase inducible degrader of the low-density lipoprotein receptor.
    Sorrentino V; Zelcer N
    Curr Opin Lipidol; 2012 Jun; 23(3):213-219. PubMed ID: 22510808
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hsa-miR-140-5p down-regulates LDL receptor and attenuates LDL-C uptake in human hepatocytes.
    Xu Y; Gao J; Gong Y; Chen M; Chen J; Zhao W; Tan S
    Atherosclerosis; 2020 Mar; 297():111-119. PubMed ID: 32109664
    [TBL] [Abstract][Full Text] [Related]  

  • 13. MicroRNA-27a decreases the level and efficiency of the LDL receptor and contributes to the dysregulation of cholesterol homeostasis.
    Alvarez ML; Khosroheidari M; Eddy E; Done SC
    Atherosclerosis; 2015 Oct; 242(2):595-604. PubMed ID: 26318398
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Curcumin nicotinate increases LDL cholesterol uptake in hepatocytes through IDOL/LDL-R pathway regulation.
    Huang Y; Liu FY; Yang JT; Zhao Q; Zhu MQ; Wang J; Long SY; Tuo QH; Zhang CP; Lin LM; Liao DF
    Eur J Pharmacol; 2024 Mar; 966():176352. PubMed ID: 38290567
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pterostilbene Increases LDL Metabolism in HL-1 Cardiomyocytes by Modulating the PCSK9/HNF1α/SREBP2/LDLR Signaling Cascade, Upregulating Epigenetic hsa-miR-335 and hsa-miR-6825, and LDL Receptor Expression.
    Lin YK; Yeh CT; Kuo KT; Yadav VK; Fong IH; Kounis NG; Hu P; Hung MY
    Antioxidants (Basel); 2021 Aug; 10(8):. PubMed ID: 34439528
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Xanthohumol Suppresses Mylip/Idol Gene Expression and Modulates LDLR Abundance and Activity in HepG2 Cells.
    Chen SF; Chen PY; Hsu HJ; Wu MJ; Yen JH
    J Agric Food Chem; 2017 Sep; 65(36):7908-7918. PubMed ID: 28812343
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Deubiquitylase USP2 Regulates the LDLR Pathway by Counteracting the E3-Ubiquitin Ligase IDOL.
    Nelson JK; Sorrentino V; Avagliano Trezza R; Heride C; Urbe S; Distel B; Zelcer N
    Circ Res; 2016 Feb; 118(3):410-9. PubMed ID: 26666640
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Relationship between porcine miR-20a and its putative target low-density lipoprotein receptor based on dual luciferase reporter gene assays.
    Ding Y; Zhu S; Wu C; Qian L; Li D; Wang L; Wang Y; Zhang W; Yang M; Ding J; Wu X; Zhang X; Gao Y; Yin Z
    Asian-Australas J Anim Sci; 2019 Jul; 32(7):922-929. PubMed ID: 30744358
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cholesterol in LDL receptor recycling and degradation.
    Yang HX; Zhang M; Long SY; Tuo QH; Tian Y; Chen JX; Zhang CP; Liao DF
    Clin Chim Acta; 2020 Jan; 500():81-86. PubMed ID: 31770510
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Cholesterol-Modulating Effect of Methanol Extract of Pigeon Pea (
    Chang HY; Wu JR; Gao WY; Lin HR; Chen PY; Chen CI; Wu MJ; Yen JH
    Molecules; 2019 Jan; 24(3):. PubMed ID: 30704067
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.